Nilandron is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cenexi Hsc. The primary component is Nilutamide.
Product ID | 82454-0111_d44e4842-09c8-72e9-e053-2a95a90a7c44 |
NDC | 82454-0111 |
Product Type | Human Prescription Drug |
Proprietary Name | Nilandron |
Generic Name | Nilutamide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-07-15 |
Marketing Category | NDA / |
Application Number | NDA020169 |
Labeler Name | CENEXI HSC |
Substance Name | NILUTAMIDE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2013-07-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
59212-111 | Nilandron | Nilutamide |
82454-0111 | Nilandron | Nilutamide |
62559-173 | Nilutamide | Nilutamide |
66993-212 | Nilutamide | Nilutamide |
82454-0212 | Nilutamide | Nilutamide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NILANDRON 74646174 1949186 Live/Registered |
CONCORDIA PHARMACEUTICALS INC. 1995-03-13 |